comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 18:48:04 - browse：4

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Poor hospice wound care hurts patients and families

Wikipedia

WSS

Congress must reauthorize a committee to support older Americans

Involuntary treatment for addiction doesn't work

Involuntary treatment for addiction doesn't work

Astellas still sees hope in its gene therapy after four deaths

Celiac disease study examines precisely how gluten triggers injury

Hospitals look to new technology to keep health care workers safe

explore

comprehensive

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Argenx drug significantly slows progression of nerve disorder

Heart attack and stroke risk calculators need revising

J&J expands global access to TB drug amid advocacy campaign

Jerome Adams on the need for new antivirals for Covid

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

In Memoriam: Notable people who died in 2023

Ransomware attacks on hospitals: Study outlines patient impact

Hepatitis C has a cure — but many Americans still lack access to it

Europe sees delivery challenges ahead on Alzheimer's therapies

hotspot

The new HIV moral panic

Weight loss drug costs may need more research, senator suggests

Congress: Eradicate hepatitis C and reduce the deficit

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Anthos stroke drug appears safer than common blood thinner

A daunting task: navigating dual Medicare, Medicaid eligibility

focus

knowledge

Wikipedia

hotspot